Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Brennan Karen — Checkmate Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Brennan Karen

Brennan Karen

Chief Operating Officer at Checkmate Pharmaceuticals, Inc. · on record since Aug 10, 2020

Insider trading activity of Brennan Karen

Transactions on record: 1; since Aug 10, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 10, 2020

Figures computed from official regulatory filings — methodology.

Companies where Brennan Karen has traded

Checkmate Pharmaceuticals, Inc.1 tx · Aug 10, 2020

Track record of Brennan Karen

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Brennan Karen

Co-insiders of Brennan Karen

Adelman Robert JCheckmate Pharmaceuticals, Inc.
BASH ALANCheckmate Pharmaceuticals, Inc.
Chaudhary KleemCheckmate Pharmaceuticals, Inc.
Colabuono PeterCheckmate Pharmaceuticals, Inc.
Dolski RobertCheckmate Pharmaceuticals, Inc.
Flaherty Keith T.Checkmate Pharmaceuticals, Inc.
Fuhrman AlanCheckmate Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

GOODMAN COREY SCheckmate Pharmaceuticals, Inc.

HEALY JAMESCheckmate Pharmaceuticals, Inc.

Isacoff OrenCheckmate Pharmaceuticals, Inc.

Krieg Arthur MCheckmate Pharmaceuticals, Inc.

Kumar NileshCheckmate Pharmaceuticals, Inc.

Labinger BarryCheckmate Pharmaceuticals, Inc.

Lieber Jonathan ICheckmate Pharmaceuticals, Inc.

Novo A/SCheckmate Pharmaceuticals, Inc.

POWELL MICHAELCheckmate Pharmaceuticals, Inc.

Sofinnova Management IX, L.L.C.Checkmate Pharmaceuticals, Inc.

Sofinnova Venture Partners IX, L.P.Checkmate Pharmaceuticals, Inc.

venBio Global Strategic Fund II L.P.Checkmate Pharmaceuticals, Inc.

venBio Global Strategic GP II, L.P.Checkmate Pharmaceuticals, Inc.

venBio Global Strategic GP II, Ltd.Checkmate Pharmaceuticals, Inc.

Wigginton Jon MarcCheckmate Pharmaceuticals, Inc.

Wooldridge JamesCheckmate Pharmaceuticals, Inc.

Yan JoyCheckmate Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Checkmate Pharmaceuticals, Inc.	Aug 10, 2020	AwardD	53,496	0.00 USD	$0	SEC